logo
Share SHARE
FONT-SIZE Plus   Neg

Life Technologies Showcases Leading Technologies For Cancer Research At AACR

Life Technologies Corp. (LIFE) said it will exhibit products across the spectrum of basic, translational and clinical cancer research during the American Association of Cancer Research or AACR Annual Meeting 2012, taking place March 31 - April 4, in Chicago, Illinois.

Presentations included in this exhibition are triple negative breast cancer, Semiconductor sequencing of melanoma samples, the company said.

Triple negative breast tumors, which make up nearly 20 percent of breast cancers, do not respond to treatment with targeted therapies such as Herceptin. To investigate new options for these patients, the first clinical trial of whole-genome sequencing for women with triple negative breast cancer was initiated in March 2010; early results will be presented by John Carpten, head of the Integrated Cancer Genomics Division at the Phoenix-based Translational Genomics Research Institute or Tgen.

In addition, George Watts, research assistant professor and co-director of the Genomics Shared Service at The University of Arizona Cancer Center, will present a poster demonstrating accurate, cost-effective sequencing of six commonly mutated genes in archived research samples from metastatic melanoma patients using the Life Technologies Ion Personal Genome Machine system.

by RTT Staff Writer

For comments and feedback: editorial@rttnews.com

Business News

Quick Facts

Editors Pick
Aerospace and defense giant Boeing Co. on Wednesday reported a turnaround to profit in the second quarter as lower revenues were more than offset by a decline in costs and expenses. Adjusted earnings per share beat analysts' expectations, while revenues missed their estimates. Looking ahead to fiscal 2017, the company raised its outlook for earnings. Coca-Cola Company (KO) reported a profit for the second-quarter 2017 that declined 60 percent from the prior year, as the company incurred a charge of $653 million related to refranchising its North America bottling operations. The company reaffirmed full year underlying performance outlook, but raised full year comparable earnings per share target on diminished currency headwinds. Ford Motor Company (F) reported second-quarter adjusted EPS of $0.56, up $0.04 year over year. On average, 21 analysts polled by Thomson Reuters expected the company to report profit per share of $0.43 for the quarter. Analysts' estimates typically exclude special items. However, adjusted pre-tax profit...
comments powered by Disqus
Follow RTT